Optomed Plc     Stock Exchange Release             3 April 2020 at 9.00, Helsinki

Optomed postpones its Annual General Meeting

Optomed postpones its Annual General Meeting due to the COVID-19 pandemic. Previously, the Company has informed that the meeting will be held on 28 April 2020.

The new date of the Annual General Meeting will be disclosed in due course. The meeting will be arranged in accordance with all the regulatory guidelines and ensuring the health and safety of shareholders and Optomed personnel. Optomed will convene the Annual General Meeting at a later stage.

Optomed Plc
 

Further enquiries

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com (sakari.knuutti@optomed.com)

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology. In 2019, Optomed's revenue reached EUR 15 million and 2018 pro forma revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108 professionals.